Skip to main content

7 Result(s)

within S Bork Remove this filter

and

  1. No Access

    Article

    Treatment with PB125® Increases Femoral Long Bone Strength in 15-Month-Old Female Hartley Guinea Pigs

    Nuclear factor-erythroid 2-related factor-2 (Nrf2) is a transcription factor that serves as a master regulator of anti-inflammatory agents, phase I xenobiotic, and phase II antioxidant enzymes, all of which pr...

    K. M. Andrie, D. R. Palmer, O. Wahl, S. Bork… in Annals of Biomedical Engineering (2024)

  2. No Access

    Article

    Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase

    In this study, we provide a molecular signature of highly enriched CD34+ cells from bone marrow of untreated patients with chronic myelogenous leukemia (CML) in chronic phase in comparison with normal CD34+ ce...

    E Diaz-Blanco, I Bruns, F Neumann, J C Fischer, T Graef, M Rosskopf, B Brors… in Leukemia (2007)

  3. No Access

    Article

    Lactate production upon short-term non–ischemic forearm exercise in mitochondrial disorders and other myopathies

    The nonischemic forearm exercise test (NIFET) has been shown to be as effective as the classic ischemic forearm exercise test (IFET) in the diagnosis of patients with Mc Ardle disease. Recently, the lactate in...

    Dr. med. F. Hanisch, K. Eger, S. Bork, H. Lehnich, M. Deschauer… in Journal of Neurology (2006)

  4. No Access

    Article

    Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib

    F Neumann, N Teutsch, S Kliszewski, S Bork, U Steidl, B Brors, N Schimkus… in Leukemia (2005)

  5. No Access

    Article

    Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma

    Following induction therapy and 4 g/m2 cyclophosphamide, a single dose of 12 mg polyethyleneglycol-conjugated G-CSF (pegfilgrastim; n=12) or daily doses of unconjugated G-CSF (8.5 μg/kg/day) (n=12) were administe...

    U Steidl, R Fenk, I Bruns, F Neumann, M Kondakci, B Hoyer… in Bone Marrow Transplantation (2005)

  6. No Access

    Chapter

    Praktische Durchführung der Elektrokrampftherapie

    Die Elektrokrampfbehandlung wird in Allgemeinnarkose durchgeführt. Sowohl die Durchführung als auch die Aufklärung des Patienten über die Narkose sind Aufgabe des Anästhesisten. Das Wissenswerte für den, der d...

    S. Bork in Elektromagnetische Therapien in der Psychiatrie (2003)

  7. No Access

    Chapter

    Subjektives Erleben der Elektrokrampftherapie

    Ein erhebliches Problem in der praktischen Anwendung der Elektro-krampfbehandlung ist das nach wie vor schlechte Image der EKT in der Allgemeinbevölkerung sowie auch unter Teilen der Ärzte und Psychotherapeute...

    S. Bork in Elektromagnetische Therapien in der Psychiatrie (2003)